Samco ELSS Tax Saver Fund
The scheme seeks to generate long-term capital appreciation through investments made predominantly in equity and equity related instruments.
Growthvine rating: 1/5 — ranked #37 of 39 in category.
Fund basics
| Category | Equity: ELSS |
|---|
| NAV | ₹12.92 (as of 2026-11-13) |
|---|
| AUM | ₹104 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Umeshkumar Mehta |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Sharpe ratio | -0.12 |
|---|
| Standard deviation | 19.74% |
|---|
| Max drawdown | −29.88% |
|---|
| Alpha | -7.83 |
|---|
| Beta | 1.07 |
|---|
Over 5 years, captured 89.3% of Nifty 500's upside and 110.3% of its downside.
Market cap allocation
| Large cap | 2.9% |
|---|
| Mid cap | 25.7% |
|---|
| Small cap | 71.4% |
|---|
Concentration
| Top 5 holdings | 21.1% |
|---|
| Top 10 holdings | 39.1% |
|---|
| Total holdings | 35 |
|---|
| Index overlap | 4.7% |
|---|
| Active share | 95.3% |
|---|
Top holdings
- Welspun Corp Limited — 4.6%
- Ather Energy Limited — 4.4%
- Federal Bank Ltd. — 4.4%
- Syrma SGS Technology Limited — 3.9%
- Sai Life Sciences Limited — 3.8%
- Apar Industries Ltd — 3.7%
- Gland Pharma Limited — 3.7%
- Kirloskar Oil Engines Limited — 3.6%
- Anand Rathi Wealth Limited — 3.5%
- Sona BLW Precision Forgings Limited — 3.4%
Top sectors
- Industrial Products — 22.0%
- Pharma & Biotech — 17.0%
- Automobile — 15.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 1.5% | Q2 | #20 of 39 |
| 2025 | −12.6% | Q4 (Bottom) | #38 of 38 |
| 2024 | 8.7% | Q4 (Bottom) | #37 of 38 |
| 2023 | 33.6% | Q1 (Top) | #5 of 35 |